Usana health sciences, inc. (USNA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net earnings

102,906

100,526

102,103

108,921

121,450

126,224

88,042

80,771

70,123

62,535

90,268

96,597

99,100

100,041

102,126

97,637

97,291

94,672

92,005

85,894

79,779

76,636

75,618

72,873

77,782

79,024

77,189

77,926

70,461

66,433

61,147

56,042

53,153

50,752

0

0

0

Adjustments to reconcile net earnings to net cash provided by (used in) operating activities
Depreciation and amortization

14,371

14,743

15,296

15,812

16,178

16,843

17,047

17,129

17,175

16,110

15,349

14,394

13,428

13,482

12,624

12,102

11,161

9,978

9,409

9,032

8,936

8,810

8,859

8,821

8,952

9,044

9,088

9,047

8,933

8,826

8,721

8,638

8,534

8,474

0

0

0

Right-of-use asset amortization

8,496

8,264

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Gain) loss on sale of property and equipment

-

-84

-38

-54

-46

-1,805

-1,814

-1,801

-1,810

-18

-69

-70

-67

-116

-57

-15

-17

-3

-16

-58

-67

-46

-38

-6

9

16

-47

-66

17

36

0

0

0

-

-

-

-

Equity-based compensation expense

15,103

15,541

16,613

16,498

14,982

14,955

14,797

14,538

15,089

15,482

14,290

15,123

16,131

16,542

18,092

16,114

13,480

11,081

10,828

10,122

10,179

9,805

7,440

7,268

7,091

7,624

8,139

9,019

9,713

10,210

10,994

11,365

10,180

10,549

0

0

0

Excess tax benefits from equity-based payment arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,024

20,577

17,183

13,888

14,834

3,892

9,119

9,137

7,466

8,234

4,797

3,452

3,443

2,779

380

189

48

0

0

0

Deferred income taxes

-2,072

-3,635

-6,411

-4,730

645

699

28,583

16,056

21,028

19,306

-14,252

-3,860

-388

-3,700

-2,828

-3,426

-3,927

-2,572

-2,183

-1,463

-1,470

-1,039

-1,231

-634

1,487

814

3,052

9,627

4,021

4,111

2,129

-4,291

-585

-1,599

0

0

0

Changes in operating assets and liabilities:
Inventories

-21,773

-12,990

-2,698

15,684

22,262

23,101

20,440

5,786

-4,850

-6,054

-11,444

-2,152

3,907

1,034

12,561

18,406

17,710

23,071

22,286

11,386

4,696

-1,102

-3,172

2,626

5,216

11,783

13,091

8,219

7,337

-1,370

-3,917

-818

1,664

3,209

0

0

0

Prepaid expenses and other assets

-1,447

-7,189

-8,841

-7,156

-3,233

1,626

3,729

5,209

2,125

-5,010

-8,773

-6,669

7,026

9,749

13,661

7,972

1,904

2,047

3,830

4,367

-440

3,789

-164

10,314

17,940

8,465

6,271

8,304

619

6,341

11,262

1,417

1,283

-4,024

0

0

0

Income tax payable related to tax benefit from equity award activity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,024

20,373

17,061

13,766

14,712

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-89

1,835

-5,823

-887

-619

-1,720

5,348

4,776

3,429

3,043

-1,388

-2,608

1,003

-1,341

1,210

1,396

-389

2,481

3,780

2,913

3,156

-1,337

-1,507

-450

-2,011

2,790

1,126

735

426

-985

-2,175

-1,977

-252

1,502

0

0

0

Other liabilities

-9,998

-30,804

-28,031

-15,512

3,104

18,698

33,288

-789

7,278

-6,518

-761

15,981

6,913

22,534

13,478

15,816

3,357

20,941

24,772

29,421

30,008

15,073

2,033

6,560

11,127

20,252

20,923

9,148

6,431

10,753

9,576

13,927

7,289

-382

0

0

0

Total adjustments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Net cash provided by (used in) operating activities

151,998

126,733

111,419

115,605

138,122

152,119

166,826

125,363

141,391

123,774

123,792

144,518

125,321

136,891

118,689

113,276

101,376

111,466

112,307

120,102

126,277

105,185

101,695

82,847

81,057

98,893

93,775

96,155

90,467

92,805

80,263

82,653

75,206

70,108

0

0

0

Cash flows from investing activities
Additions to notes receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

7

5

6

36

1,580

2,915

3,553

4,613

4,495

4,738

5,230

5,229

4,942

0

0

0

-

-

-

-

-

-

-

-

Receipts on notes receivable

261

231

193

181

4,603

4,849

4,838

4,797

490

296

465

627

869

811

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for net investment hedge

1,089

1,660

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of investment securities held-to-maturity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,871

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of investment securities held-to-maturity

-

63,539

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,511

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of property and equipment

-

17

11

6

352

381

387

392

47

22

0

0

0

-

-

-

-

-

-

-

-

10

10

40

50

47

53

21

106

154

0

0

0

-

-

-

-

Purchases of property and equipment

21,258

16,569

13,943

11,927

11,062

11,433

12,914

12,887

12,787

13,220

15,819

26,004

27,108

32,698

33,308

27,614

26,858

23,729

23,623

20,096

25,284

20,421

15,011

15,193

8,158

8,051

7,927

7,946

7,077

8,432

8,896

8,296

12,194

10,643

0

0

0

Net cash provided by (used in) investing activities

6,715

47,494

68,210

27,970

-33,882

-69,003

-88,623

-49,392

-12,250

-12,902

-15,333

-25,359

-26,222

-31,883

-32,702

-26,991

-26,660

-25,124

-26,356

-20,273

-25,466

-16,266

-19,742

-23,760

-17,767

-21,589

-11,237

-10,157

-8,113

-8,278

-8,715

-8,115

-12,109

-10,609

0

0

0

Cash flows from financing activities
Excess tax benefits from equity-based payment arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,024

20,577

17,183

13,888

14,834

3,892

9,119

9,137

7,466

8,234

4,797

3,452

3,443

2,779

380

189

48

0

0

0

Repurchase of common stock

177,029

150,000

229,785

160,055

132,432

105,375

0

0

0

-

-

-

-

64,610

0

0

0

-

-

-

-

-

-

-

-

18,085

0

0

0

-

-

-

-

33,459

0

0

0

Borrowings on line of credit

-

5,000

0

0

0

-

-

-

-

-

-

-

-

73,700

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on line of credit

-

5,000

0

0

0

-

-

-

-

-

-

-

-

73,700

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments related to tax withholding for net-share settled equity awards

2,397

1,987

2,115

2,097

1,914

809

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

250

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

-179,491

-152,052

-231,965

-162,152

-133,439

-105,277

0

0

0

-

-

-

-

-64,860

-122,556

-119,753

-48,927

-49,157

5,390

-64,557

-113,961

-113,015

-108,770

-36,990

9,591

-10,165

-43,433

-54,888

-82,618

-64,542

-31,928

-33,671

-24,709

-33,372

0

0

0

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-10,327

-1,721

-4,879

-6,614

-12,489

-11,140

-5,238

3,576

14,589

11,027

-144

-2,459

-7,577

-7,929

-3,083

-5,063

-3,857

-5,101

-4,884

-2,610

-1,014

-2,121

-794

114

-1,195

-635

-357

-592

147

501

664

-273

58

4

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

-31,105

20,454

-57,215

-25,191

-41,688

-33,301

47,715

26,835

90,163

71,583

56,990

116,700

25,522

32,219

-39,652

-38,531

21,932

32,084

86,457

32,662

-14,164

-26,217

-27,611

22,211

71,686

66,504

38,748

30,518

-117

20,486

40,284

40,594

38,446

26,131

0

0

0

Cash paid during the period for:
Interest

8

11

11

9

9

6

12

14

16

16

15

12

178

323

0

0

0

-

-

-

-

136

0

0

0

-

-

-

-

-

-

-

-

10

0

0

0

Income taxes

54,445

54,914

57,105

59,300

61,351

70,683

64,718

71,609

55,414

46,006

51,997

45,365

54,079

52,579

57,978

48,947

41,373

35,782

34,157

31,970

29,164

26,955

13,114

15,875

26,638

26,952

27,677

34,878

27,491

27,131

30,266

24,349

24,936

24,539

0

0

0

Cash received during the period for:
Income tax refund

-

5,542

5,679

5,801

7,744

2,698

2,451

2,066

49

4,700

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease obligations

14,886

33,258

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Credits on notes receivable

-

-

-

-

-

-

-

-

-

86

558

627

974

1,288

1,642

1,762

1,416

966

586

660

713

720

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued purchases of property and equipment

1,355

998

368

703

287

195

0

0

0

-

-

-

-

2,216

6,720

9,047

8,608

6,863

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-